University of Illinois at Chicago Cancer Center — Chicago, Illinois

University of Illinois at Chicago Cancer Center is a clinical research site located in Chicago, Illinois, United States 60612-7243.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Illinois at Chicago Cancer Center has participated in 9 clinical trials with 1 currently active.

Therapeutic areas: Neuroblastoma, Lymphoid Malignancies, Liver Cancer.

Sponsors: Children's Oncology Group, AVM Biotechnology Inc, Eximias Pharmaceutical.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Illinois at Chicago Cancer Center?

University of Illinois at Chicago Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Illinois at Chicago Cancer Center conducted?

University of Illinois at Chicago Cancer Center has 9 clinical trials on record, with 1 currently active. Their work covers Neuroblastoma, Lymphoid Malignancies, Liver Cancer.

Is University of Illinois at Chicago Cancer Center accredited by Crixeo Health?

Yes — University of Illinois at Chicago Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Illinois at Chicago Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.